Tenon Medical Reports Unregistered Equity Sales
Ticker: TNONW · Form: 8-K · Filed: Oct 16, 2025 · CIK: 1560293
| Field | Detail |
|---|---|
| Company | Tenon Medical, Inc. (TNONW) |
| Form Type | 8-K |
| Filed Date | Oct 16, 2025 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: unregistered-sales, equity-securities, warrants
Related Tickers: TNON
TL;DR
Tenon Medical sold unregistered stock and warrants on Oct 13, 2025.
AI Summary
On October 13, 2025, Tenon Medical, Inc. filed an 8-K report detailing unregistered sales of equity securities. The filing indicates the company issued warrants and common stock, though specific details on the number of shares, exercise prices, or total proceeds were not immediately available in this excerpt.
Why It Matters
This filing signals potential dilution for existing shareholders and provides insight into the company's methods of raising capital through non-public offerings.
Risk Assessment
Risk Level: medium — Unregistered sales can indicate a need for capital and may lead to dilution, but the specific terms and amounts are crucial for a full risk assessment.
Key Players & Entities
- Tenon Medical, Inc. (company) — Registrant
- October 13, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 104 Cooper Court, Los Gatos, CA 95032 (address) — Principal executive offices
FAQ
What type of equity securities were sold?
The filing indicates unregistered sales of equity securities, specifically mentioning common stock and warrants.
When did the earliest event reported in this filing occur?
The earliest event reported occurred on October 13, 2025.
What is Tenon Medical, Inc.'s state of incorporation?
Tenon Medical, Inc. is incorporated in Delaware.
What is the principal executive office address for Tenon Medical, Inc.?
The principal executive office is located at 104 Cooper Court, Los Gatos, CA 95032.
What is the filing's SEC Act and Form Type?
The filing is made under the 1934 Act as a Form 8-K.
Filing Stats: 497 words · 2 min read · ~2 pages · Grade level 11.9 · Accepted 2025-10-16 16:45:46
Key Financial Figures
- $0.001 — ch registered Common Stock, par value $0.001 per share TNON The Nasdaq Stock Mar
Filing Documents
- ea0261386-8k_tenon.htm (8-K) — 28KB
- 0001213900-25-099596.txt ( ) — 231KB
- tnon-20251013.xsd (EX-101.SCH) — 4KB
- tnon-20251013_def.xml (EX-101.DEF) — 26KB
- tnon-20251013_lab.xml (EX-101.LAB) — 36KB
- tnon-20251013_pre.xml (EX-101.PRE) — 25KB
- ea0261386-8k_tenon_htm.xml (XML) — 5KB
02. Unregistered Sales of Equity Securities
Item 3.02. Unregistered Sales of Equity Securities. On October 13, 2025, Tenon Medical, Inc., Delaware corporation (the "Company"), issued its directors and officers an aggregate 866,642 restricted stock units ("RSUs") pursuant to the Tenon Medical, Inc. 2022 Equity Incentive Plan, as amended. All RSUs will vest and automatically convert into the shares of common stock of the Company on one-for-one basis in two installments: 50% on January 1, 2026, and 50% on July 31, 2026. The Company issued the RSUs as described above in reliance on exemption from the registration requirements of the Securities Act of 1933, as amended (the "Securities Act"), available to the Company under Section 4(a)(2) of the Securities Act due to the fact that the issuance did not involve a public offering of securities. 1
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this Current Report on Form 8-K to be signed on its behalf by the undersigned hereunto duly authorized. Date: October 16, 2025 TENON MEDICAL, INC. (Registrant) By: /s/ Kevin Williamson Name: Kevin Williamson Title: Chief Financial Officer 2